Brookings conference on post-market safety
Executive Summary
Brookings Institution's Engelberg Center for Health Care Reform will hold a conference in Washington, D.C., June 13 on drug safety and post-market evidence, hosted by center Director Mark McClellan. During the conference, FDA Commissioner Andrew von Eschenbach and CDER Director Janet Woodcock are scheduled to discuss the agency's new Sentinel initiative, along with Richard Platt, Harvard University, Marcus Wilson, from WellPoint's HealthCore unit, and Janet Marchibroda, eHealth Initiative. Some details on the Sentinel project were announced by FDA May 22. Other conference participants will include Garry Neil, J&J, and Arnold Chan, i3 Drug Safety
You may also be interested in...
Building the Right Foundation: An Interview with Mark McClellan
The Reagan-Udall Foundation is an early priority for FDA in implementing the landmark legislation enacted by Congress in 2007. It is also a lightning road for criticism from Congress about the agency's relationship with regulated industry. We asked foundation chairman Mark McClellan for a status report.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.